Seagen Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 10.14
Dividend & YieldN/A$ (N/A)
Beta 0.6
Market capitalization 21.79B
Operating cash flow -657.69M
ESG Scores 27.1

Company description

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

Sector: Healthcare - Industry: Biotechnology

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -33.91M -33.6M
Total Cashflows From Investing Activities -592.63M -277.73M -1.42B 288.88M
Net Borrowings
Total Cash From Financing Activities 713.41M 637.84M 846.11M 77.78M
Change To Operating Activities 20.19M 43.25M 161.79M 60.78M
Issuance Of Stock 713.41M 637.84M 846.11M 77.78M
Net Income -222.69M -158.65M 613.67M -674.47M
Change In Cash -82.76M 196.38M 283.86M -133.59M
Effect Of Exchange Rate 198k 198k 198k -1.25M
Total Cash From Operating Activities -203.54M -163.74M 856.57M -499.01M
Depreciation 26.03M 33.51M 63.38M 78.63M
Change To Account Receivables -45.23M -89.72M -88.73M -64.27M
Other Cashflows From Financing Activities
Change To Netincome 45.34M 74.16M 136.65M 184.85M
Capital Expenditures -21.22M -70.75M -82.41M -52.33M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 565.31M
Income Before Tax -246.35M -158.65M 615.7M -675.71M
Net Income -222.69M -158.65M 613.67M -674.47M
Selling General Administrative 252.6M 373.93M 533.84M 716.19M
Gross Profit 1.1M 153.39M 1.13B 34.13M
Ebit -251.5M -220.54M 596.85M -682.06M
Operating Income -251.5M -220.54M 596.85M -682.06M
Interest Expense
Income Tax Expense -23.65M 2.03M -1.23M
Total Revenue 654.7M 916.71M 2.18B 1.57B
Cost Of Revenue 653.6M 763.33M 1.04B 1.54B
Total Other Income ExpenseNet 5.15M 61.9M 18.85M 6.35M
Net Income From Continuing Ops -222.69M -158.65M 613.67M -674.47M
Net Income Applicable To Common Shares -222.69M -158.65M 613.67M -674.47M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 229.39M 329.58M 512.81M 654.47M
Total Stockholder Equity 1.27B 1.88B 3.49B 3.07B
Other Current Liabilities 66.51M 37.66M 52.56M 81.32M
Total Assets 1.5B 2.21B 4B 3.72B
Common Stock 160k 172k 181k 183k
Other Current Assets
Retained Earnings -1.32B -1.48B -869.57M -1.54B
Treasury Stock -40k 229k 565k 1.18M
Cash 78.19M 274.56M 558.42M 424.83M
Total Current Liabilities 225.07M 259.36M 388.14M 568.85M
Other Stockholder Equity -40k 229k 565k 1.18M
Property, Plant, and Equipment 103.82M 220.72M 258.18M 267.96M
Total Current Assets 653.6M 1.18B 3.06B 2.87B
Net Tangible Assets 999.27M 1.3B 2.93B 2.53B
Net Receivables 146.28M 236M 330.29M 389.66M
Accounts Payable 44.18M 52.29M 78.07M 114.82M


Insider Transactions

Here are the insider transactions of stock shares related to Seagen Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
LIU JEAN ISale at price 131.05 per share.D2022-11-17Officer8.33k
LIU JEAN IConversion of Exercise of derivative security at price 34.20 per share.D2022-11-17Officer8.33k
LIU JEAN IConversion of Exercise of derivative security at price 76.86 per share.D2022-11-14Officer1.3k
GRYSKA DAVID WSale at price 129.10 per share.D2022-11-11Director7.5k
EPSTEIN DAVID RStock Award(Grant) at price 0.00 per share.D2022-11-09Chief Executive Officer107.39k
DANSEY ROGER DSale at price 135.00 per share.D2022-10-17Chief Executive Officer10k
DANSEY ROGER DConversion of Exercise of derivative security at price 65.11 - 77.45 per share.D2022-10-17Chief Executive Officer10k
SIMPSON TODD ESale at price 154.41 per share.D2022-08-31Chief Financial Officer4.19k
LIU JEAN ISale at price 154.41 per share.D2022-08-31Officer3.65k
HIMES VAUGHN BSale at price 154.41 per share.D2022-08-31Chief Technology Officer3.58k
DANSEY ROGER DSale at price 154.41 per share.D2022-08-31Chief Executive Officer5.02k
ROMP CHARLES RSale at price 154.41 per share.D2022-08-31Officer1.13k
SIMPSON TODD ESale at price 170.22 per share.D2022-08-16Chief Financial Officer1.97k
LIU JEAN ISale at price 170.22 per share.D2022-08-16Officer1.64k
HIMES VAUGHN BSale at price 170.22 per share.D2022-08-16Chief Technology Officer1.53k
DANSEY ROGER DSale at price 170.22 per share.D2022-08-16Chief Executive Officer4.25k
ROMP CHARLES RSale at price 170.22 per share.D2022-08-16Officer1.76k
SIMPSON TODD EStock Award(Grant) at price 0.00 per share.D2022-08-15Chief Financial Officer15.45k
LIU JEAN IStock Award(Grant) at price 0.00 per share.D2022-08-15Officer13.73k
HIMES VAUGHN BStock Award(Grant) at price 0.00 per share.D2022-08-15Chief Technology Officer12.01k
DANSEY ROGER DStock Award(Grant) at price 0.00 per share.D2022-08-15Chief Executive Officer44.62k
ROMP CHARLES RStock Award(Grant) at price 0.00 per share.D2022-08-15Officer13.73k
ROMP CHARLES RSale at price 179.46 per share.D2022-07-05Officer712
DANSEY ROGER DSale at price 180.00 per share.D2022-06-28Officer34.63k
DANSEY ROGER DConversion of Exercise of derivative security at price 65.11 per share.D2022-06-28Officer19.74k
HIMES VAUGHN BSale at price 160.00 per share.I2022-06-17Chief Technology Officer1.13k
HIMES VAUGHN BConversion of Exercise of derivative security at price 41.04 per share.D2022-06-17Chief Technology Officer1.13k
HIMES VAUGHN BSale at price 136.40 - 138.61 per share.D2022-05-24Chief Technology Officer10.87k
HIMES VAUGHN BConversion of Exercise of derivative security at price 26.10 per share.D2022-05-24Chief Technology Officer10.87k
ROMP CHARLES RSale at price 134.21 per share.D2022-05-16Officer333
GRYSKA DAVID WStock Award(Grant) at price 0.00 per share.D2022-05-13Director1.5k
BAKER BROS ADVISORS L.P.Stock Award(Grant) at price 0.00 per share.I2022-05-13Beneficial Owner of more than 10% of a Class of Security3.01k
WELCH DANIEL GStock Award(Grant) at price 0.00 per share.D2022-05-13Director1.5k
SIMONIAN NANCY AStock Award(Grant) at price 0.00 per share.D2022-05-13Director1.5k
ORWIN JOHN AStock Award(Grant) at price 0.00 per share.D2022-05-13Director1.5k
SETH ALPNAStock Award(Grant) at price 0.00 per share.D2022-05-13Director1.5k
LOVE TED WENDELLStock Award(Grant) at price 0.00 per share.D2022-05-13Director1.5k
SIEGALL CLAY BSale at price 125.39 - 126.18 per share.D2022-05-12Chief Executive Officer17.04k
SIEGALL CLAY BConversion of Exercise of derivative security at price 26.10 per share.D2022-05-12Chief Executive Officer17.04k
DANSEY ROGER DSale at price 144.15 - 144.32 per share.D2022-04-21Officer1.44k
SIMPSON TODD ESale at price 144.32 per share.D2022-04-20Chief Financial Officer567
LIU JEAN ISale at price 144.32 per share.D2022-04-20Officer401
SIEGALL CLAY BSale at price 144.32 per share.D2022-04-20Chief Executive Officer1.89k
HIMES VAUGHN BSale at price 144.32 per share.D2022-04-20Chief Technology Officer574
ROMP CHARLES RSale at price 144.32 per share.D2022-04-20Officer319
GRYSKA DAVID WSale at price 143.32 - 145.08 per share.D2022-04-19Director4k
GRYSKA DAVID WConversion of Exercise of derivative security at price 20.06 per share.D2022-04-19Director4k
SIEGALL CLAY BSale at price 151.42 - 157.23 per share.D2022-04-07Chief Executive Officer17.04k
SIEGALL CLAY BConversion of Exercise of derivative security at price 26.10 per share.D2022-04-07Chief Executive Officer17.04k
BAKER BROS ADVISORS L.P.Conversion of Exercise of derivative security at price 20.06 per share.I2022-03-08Beneficial Owner of more than 10% of a Class of Security35k
SIEGALL CLAY BSale at price 132.72 - 136.33 per share.D2022-03-07Chief Executive Officer17.04k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Seagen Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Seagen Inc

Here is the result of two systematic investment strategies applied to Seagen Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Seagen Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Seagen Inc:

Seagen Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 69.63% on the backtest period.

Performance at glance

Performance

69.63 %

Latent gain

1589.5 $

Invested capital

2282.66 $

Annualized return

16.82 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Seagen Inc

This is the result of two momentum investment strategies applied to Seagen Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Seagen Inc

The following chart shows all the entries opened by the momentum investment system on Seagen Inc:

Seagen Inc momentum entries
  • The first momentum investment strategy would give 94.07% of return on Seagen Inc. That represents 6100.11$ of latent gain with 6484.41$ of employed capital.
  • The second momentum investment strategy would give 65.24% of return on Seagen Inc. That represents 2293.3$ of latent gain with 3514.94$ of employed capital.
Performance at glance (1Q Momentum)

Performance

94.07 %

Latent gain

6100.11 $

Invested capital

6484.41 $

Annualized return

1.88 %
Performance at glance (2Q Momentum)

Performance

65.24 %

Latent gain

2293.3 $

Invested capital

3514.94 $

Annualized return

17.83 %

Momentum equity curve on Seagen Inc

The following chart shows the equity curve of the two momentum strategies applied to Seagen Inc:

Seagen Inc momentum equity

Note: the dividends potentially given by Seagen Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Seagen Inc

The following chart shows the employed capital evolution of the two momentum strategies on Seagen Inc since the beginning:

Seagen Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Seagen Inc

Buy the dip entry openings on Seagen Inc

Seagen Inc

The performance achieved by the robo-advisor on Seagen Inc is 4.03%. That represents 37.48$ of latent gain with 930.56$ of employed capital. The following chart shows Seagen Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Seagen Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

4.03 %

Latent gain

37.48 $

Invested capital

930.56 $

Annualized return

1.88 %

Equity curve of the strategy applied to Seagen Inc

The following chart shows the result of the investment strategy applied to Seagen Inc:

Seagen Inc

Note: the dividends potentially given by Seagen Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Seagen Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Seagen Inc:

Seagen Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Seagen Inc

In this section, I will compare the three previous investment strategies applied to Seagen Inc.

Equity curve comparison on Seagen Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Seagen Inc investment strategy comparison

Employed capital comparison on Seagen Inc

Seagen Inc investment comparison

Performance comparison on Seagen Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 69.63% 1589.5$ 2282.66$ 16.82%
Momentum 1 quarter 94.07% 6100.11$ 6484.41$ 24.12%
Momentum 2 quarters 65.24% 2293.3$ 3514.94$ 17.83%
Non-directional 4.03% 37.48$ 930.56$ 1.88%
Annualized return comparison

Automatic investment

16.82 %

Momentum 1Q

17.83 %

Momentum 2Q

17.83 %

Non-directional

1.88 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Seagen Inc:

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months


Note: The algorithm computes the probability of correlation between Seagen Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Seagen Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Seagen Inc
Country United States
City Bothell
Address 21823 30th Drive SE
Phone 425 527 4000
Website www.seagen.com
FullTime employees 2675
Industry Biotechnology
Sector Healthcare
Exchange XNAS
Ticker SGEN
Market www.nasdaq.com

Seagen Inc ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 1.8
Peer Environment Performance 2.0330864197531
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 17.3
Peer Social Performance 14.299012345679
Social Percentile unknown
Highest Controversy 1
Peer Highest Controversy Performance 1.8780487804878
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic no
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Governance Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 8.1
Peer Governance Performance 8.8141975308642
Governance Percentile unknown

ESG at glance
Total ESG Scores: 27.1
Environment Score: 1.8
Social Score: 17.3
Governance Score: 8.1

ESG Performance: AVG_PERF

Peer Group: Pharmaceuticals

Peer Esg Score Performance: 25.306097560976

Rating Year: 2022

Rating Month: 8

Max Age: 86400

Percentile: 52